2023 / 06

Next Paper
DOI: 10.24075/brsmu.2023.051

CLINICAL CASE

Methods for combination treatment of metastatic uveal melanoma

Kolomiets KV, Ponomareva ES, Posypina YaR, Mihailov II, Mandzhiev CB, Povetkina EV, Tuguz RR, Bulgakov SM, Repunova VI
About authors

Rostov State Medical University, Rostov-on-Don, Russia

Correspondence should be addressed: Karina V. Kolomiets
Krasnoarmeiskaya, 198, Novocherkassk, 346400, Russia; ur.liam@99_steimolok_anirak

About paper

Author contribution: Kolomiets KV — manuscript writing, editing; Ponomareva ES, Posypina YaR — manuscript writing, literature review, data analysis; Mihailov II, Mandzhiev CB — manuscript writing, literature review, data acquisition; Bulgakov SM, Repunova VI — manuscript writing, literature review, concept and design; Povetkina EV, Tuguz RR — manuscript writing, literature review, manuscript revision.

Compliance with ethical standards: the patient submitted the informed consent to publication of the anonymized personal medical data.

Received: 2023-10-22 Accepted: 2023-11-29 Published online: 2023-12-22
|
  1. Carle X, Gastaud L, Salleron J, Tardy MP, Caujolle JP, Thyss A, et al. Optimizing the treatment of liver metastases from uveal melanomas with transarterial chemoembolization using melphalan and calibrated microspheres. Bull Cancer. 2020; 107 (12): 1274– 83. DOI: 10.1016/j.bulcan.2020.09.010.
  2. Tao YX, Li HW, Luo JT, Li Y, Wei WB. Regional chemotherapy for uveal melanoma liver metastases. Int J Ophthalmol. 2023; 16 (2): 293–300. DOI: 10.18240/ijo.2023.02.18.
  3. Aronow ME, Topham AK, Singh AD. Uveal Melanoma: 5-Year Update on Incidence, Treatment, and Survival (SEER 1973-2013). Ocul Oncol Pathol. 2018; 4 (3): 145–51. DOI: 10.1159/000480640.
  4. Gonsalves CF, Adamo RD, Eschelman DJ. Locoregional therapies for the treatment of uveal melanoma hepatic metastases. Semin Intervent Radiol. 2020; 37 (5): 508–17. DOI: 10.1055/s-0040-1720948.
  5. Sajan A, Fordyce S, Sideris A, Liou C, Toor Z, Filtes J, et al. Minimally invasive treatment options for hepatic uveal melanoma metastases. Diagnostics (Basel). 2023; 13 (11): 1836. DOI: 10.3390/diagnostics13111836.
  6. Karivedu V, Eldessouki I, Taftaf A, Zhu Z, Makramalla A, Karim NA. Nivolumab and Ipilimumab in the treatment of metastatic uveal melanoma: a single-center experience. Case Rep Oncol Med. 2019; 2019: 3560640. DOI: 10.1155/2019/3560640.
  7. Nazarova VV, Orlova KV, Utyashev IA, Yarovoy AA, Yarovaya VA, Markina IG, et al. Combined Immunotherapy for Metastatic Uveal Melanoma. Single Centre Experience. Effective Pharmacotherapy. 2023; 19 (16): 64–71. Russian.
  8. Weber JS. Immunotherapy complete response data suggest metastatic melanoma cures. 2018 Aug 09. Available from: https://www.medscape.com/viewarticle/900259?form=fpf.
  9. Van Cutsem E, Paccard C, Chiron M, Tabernero J. Impact of Prior Bevacizumab Treatment on VEGF-A and PlGF Levels and Outcome Following Second-Line Aflibercept Treatment: Biomarker Post Hoc Analysis of the VELOUR Trial. Clin Cancer Res. 2020; 26 (3): 717–25. DOI: 10.1158/1078-0432.CCR-19-1985.